Culture Biosciences

About Culture Biosciences

Culture Biosciences develops cloud-connected bioreactors that enable real-time experiment design, monitoring, and data analysis for bioprocess development. Their technology allows companies to optimize cell culture processes and accelerate product development without the constraints of traditional lab setups.

```xml <problem> Traditional bioprocess development is constrained by limited bioreactor capacity, manual data collection, and the need for on-site experiment monitoring, creating bottlenecks in optimizing cell culture processes and accelerating product development. This can lead to delays and increased costs in bringing new biopharmaceuticals and synthetic biology products to market. </problem> <solution> Culture Biosciences offers cloud-connected bioreactors and a software platform that enable remote experiment design, real-time monitoring, and comprehensive data analysis for bioprocess development. Their platform allows researchers to test more parameters, leverage flexible bioreactor capacity, and derive more comprehensive insights by running experiments and analyzing data in the cloud. The ConsoleTM software provides a centralized interface for managing experiments, accessing real-time data, and collaborating remotely. Culture Biosciences offers bioprocess development services in their own lab and is developing a series of ConsoleTM-connected bioreactors for customer labs. </solution> <features> - Cloud-connected bioreactors for remote experiment design, monitoring, and data analysis - ConsoleTM software platform for real-time data access, collaboration, and analytics - Flexible bioreactor capacity that can be easily scaled up or down to meet experimental needs - Data science support for design of experiments (DOE) - Modality-specific assays for in-depth analysis - Secure web application for managing experiments, data, and insights - Real-time monitoring and management of experiments as if the bioreactors were running in your own lab </features> <target_audience> The primary customers are companies involved in protein therapeutics, viral vectors, and synthetic biology that need to optimize cell culture processes and accelerate product development. </target_audience> <revenue_model> Culture Biosciences generates revenue through bioprocess development services and, in the future, will generate revenue through the sale of ConsoleTM-connected bioreactors. </revenue_model> ```

What does Culture Biosciences do?

Culture Biosciences develops cloud-connected bioreactors that enable real-time experiment design, monitoring, and data analysis for bioprocess development. Their technology allows companies to optimize cell culture processes and accelerate product development without the constraints of traditional lab setups.

Where is Culture Biosciences located?

Culture Biosciences is based in San Francisco, United States.

When was Culture Biosciences founded?

Culture Biosciences was founded in 2016.

How much funding has Culture Biosciences raised?

Culture Biosciences has raised 101595000.

Location
San Francisco, United States
Founded
2016
Funding
101595000
Employees
95 employees
Major Investors
Verily, National Science Foundation, Y Combinator, BoxGroup, Craft Ventures

Find Investable Startups and Competitors

Search thousands of startups using natural language

Culture Biosciences

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Culture Biosciences develops cloud-connected bioreactors that enable real-time experiment design, monitoring, and data analysis for bioprocess development. Their technology allows companies to optimize cell culture processes and accelerate product development without the constraints of traditional lab setups.

culturebiosciences.com7K+
Founded 2016San Francisco, United States

Funding

$

Estimated Funding

$100M+

Major Investors

Verily, National Science Foundation, Y Combinator, BoxGroup, Craft Ventures

Team (75+)

No team information available.

Company Description

Problem

Traditional bioprocess development is constrained by limited bioreactor capacity, manual data collection, and the need for on-site experiment monitoring, creating bottlenecks in optimizing cell culture processes and accelerating product development. This can lead to delays and increased costs in bringing new biopharmaceuticals and synthetic biology products to market.

Solution

Culture Biosciences offers cloud-connected bioreactors and a software platform that enable remote experiment design, real-time monitoring, and comprehensive data analysis for bioprocess development. Their platform allows researchers to test more parameters, leverage flexible bioreactor capacity, and derive more comprehensive insights by running experiments and analyzing data in the cloud. The ConsoleTM software provides a centralized interface for managing experiments, accessing real-time data, and collaborating remotely. Culture Biosciences offers bioprocess development services in their own lab and is developing a series of ConsoleTM-connected bioreactors for customer labs.

Features

Cloud-connected bioreactors for remote experiment design, monitoring, and data analysis

ConsoleTM software platform for real-time data access, collaboration, and analytics

Flexible bioreactor capacity that can be easily scaled up or down to meet experimental needs

Data science support for design of experiments (DOE)

Modality-specific assays for in-depth analysis

Secure web application for managing experiments, data, and insights

Real-time monitoring and management of experiments as if the bioreactors were running in your own lab

Target Audience

The primary customers are companies involved in protein therapeutics, viral vectors, and synthetic biology that need to optimize cell culture processes and accelerate product development.

Revenue Model

Culture Biosciences generates revenue through bioprocess development services and, in the future, will generate revenue through the sale of ConsoleTM-connected bioreactors.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.